
Ninlib contains Nilotinib 200 mg, a targeted therapy used to treat chronic myeloid leukemia (CML) by inhibiting abnormal cancer cell growth.
| Manufacturer | Hetero |
| Generic Name | Nilotinib |
| Strength | 200mg |
| Package size | 30 Capsules |
| Used for | Chronic myeloid leukemia |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Capsules | $110 | £81 | A$153 | ₱6,896 | د.ت320.21 | ₩147,301 | lei 498 | HK$863 | RM447 | ฿3,632 | S$139 | د.إ404.03 | ر.س413.05 | ر.ق400.51 | د.ك33.550 |
Nilotinib is a targeted cancer medicine that blocks the BCR-ABL tyrosine kinase protein, which drives the growth of leukemia cells. By inhibiting this protein, it stops or slows the multiplication of cancer cells.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.